Breaking News

Tropichem Invests in Spot-On Manufacturing

Expansion to take place at Montreal site

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Tropichem has unveiled plans for the expansion of its North American manufacturing capabilities, adding a non-sterile liquid facility for production of anti-parasiticide spot-ons and other registered product categories. Tropichem is a contract development and manufacturing organization (CDMO) that specializes in complex drug product formulation and manufacturing of veterinary pharmaceutical products.   The company’s Montreal, Canada location was chosen based on the company’s March 2018 acquisi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters